Abstract:Rationale: Neonatal lupus erythematosus (NLE) is an infrequent disease caused by transplacental maternal autoantibodies. The most common effects of NLE include cutaneous involvement and congenital heart block (CHB), although it might involve multiple organs, such as the liver, lungs, blood, and nervous or digestive systems. Izmirly PM1 and Tonello et al recently reported cutaneous manifestations of neonatal lupus and risk of subsequent CHB. The most serious complication of NLE is complete atrioventricular (AV) block. Patient concerns: We experienced 2 cases of NLE that were diagnosed in the past year in our Neonatal Intensive Care Unit. These cases showed 2 different clinical spectrums (CHB, multisystemic effects). One case was a 32-week pregnant woman with combined liver damage and fever, and her fetus was premature due to bradycardia and pericardial effusion. The second case was a young pregnant woman who had systemic lupus erythematosus for 2 years and had been taking methylprednisolone and hydroxychloroquine for a long time since her illness. When prenatal testing at 28 weeks of pregnancy showed that the fetus had CHB, the mother began taking dexamethasone. Diagnosis: The first case was diagnosed as NLE with CHB after birth, while the second was diagnosed as NLE with CHB, ductus arteriosus, and atrial septal defect when she was born at 34 weeks. Interventions: Both of 2 cases were treated with steroids, intravenous immunoglobulin, and a diuretic. But the second case was treated with isoprenaline in addition to the above. Outcomes: Both of the infants was followed up and found to be clinically normal. During the clinic follow-up of the first case, the 8-month-old infant was still asymptomatic with normal growth and development. Her heart rate fluctuated from 40 to 90 beats/minute. Lessons: Autoimmune CHB is a severe, potentially life-threatening disorder associated with passive transfer of maternal anti-Sjogren's syndrome A/Ro and anti-Sjogren's syndrome B/La autoantibodies. Mothers who are positive for these autoantibodies are recommended to have serial echocardiography and obstetric ultrasonography from the early second trimester. Newborns should be delivered at an early stage of gestation if there is evidence of pericardial effusion, ascites, increasing ventricular ectopy, reduced ventricular shortening fraction, or AV valve regurgitation. Aggressive medical management after birth should be coupled with pacemaker implantation in infants who do not respond to medical therapies alone.

Newborns with congenital complete heart block: Advice for perinatal care providers

Perinatal management of neonatal congenital complete atrioventricular block: a survey of 5 cases

Unusual Course of Congenital Complete Heart Block in an Adult: A Case Report.

Management of perioperative heart failure in neonate with cyanotic congenital heart disease

EP09.69: Prenatal diagnosis of autoimmune congenital heart block and its successful management and outcome

The clinical spectrum of autoimmune congenital heart block

Delivery room and early postnatal management of neonates with congenital heart disease

Special considerations for the stabilization and resuscitation of patients with cardiac disease in the Neonatal Intensive Care Unit

Prenatal Diagnosis of Congenital Heart Disease: The Crucial Role of Perinatal and Delivery Planning

Pulse Oximetry Screening of Newborn for Critical Congenital Heart Disease in Developing Countries

Fetal cardiology: changing the definition of critical heart disease in the newborn

Pediatric Heart Surgery in China: Progress and Challenges

Two Case Reports of Neonatal Autoantibody-Associated Congenital Heart Block.

Autoimmune congenital heart block: a case report and review of the literature related to pathogenesis and pregnancy management

Low foetal heart rate, a potentially ominous finding: case report

Conotruncal anomalies in the fetus: Referral patterns and pregnancy outcomes in a dedicated fetal cardiology unit in South India

Cardiological Findings of Babies Born to Mothers with Connective Tissue Disease

Recent Advances in the Diagnosis and Management of Congenital Heart Disease

Early Neonatal Shock: Case Report and Lessons Learned in Management

Critical Congenital Heart Disease Detection in the Screening Era: Do Not Neglect the Examination!

Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside